| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | Chief Commercial Officer | Common Stock | 217,628 | $2,370,991 | $10.89 | 02 Jan 2026 | Direct |
| OCULAR THERAPEUTIX, INC | Chief Commercial Officer | Stock Option (Right to Buy) | 197,650 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | 02 Jan 2026 | 2 | $0 | 4 | Chief Commercial Officer | 06 Jan 2026, 16:06 |
| OCUL | OCULAR THERAPEUTIX, INC | 11 Jun 2025 | 0 | $0 | 3 | Chief Commercial Officer | 23 Jun 2025, 21:12 |